Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [14849]

Analysis shows that secondary cancers following CAR T cell therapy are rare

Analysis shows that secondary cancers following CAR T cell therapy are rare

New study assesses long term risk of invasive breast cancer after pre-invasive disease

New study assesses long term risk of invasive breast cancer after pre-invasive disease

Why cancer immunotherapies don’t work for everyone

Why cancer immunotherapies don’t work for everyone

Chemotherapy becomes more efficient when senescent cells are eliminated by immunotherapy

Chemotherapy becomes more efficient when senescent cells are eliminated by immunotherapy

ASCO GU 2024: Combination of cabozantinib and atezolizumab offers hope for patients with type of advanced prostate cancer with poor prognosis

ASCO GU 2024: Combination of cabozantinib and atezolizumab offers hope for patients with type of advanced prostate...

New study finds plant-rich foods, nuts/seeds may reduce premature ageing in childhood cancer survivors

New study finds plant-rich foods, nuts/seeds may reduce premature ageing in childhood cancer survivors

Cancer GPS method evaluates model tumour malignancy

Cancer GPS method evaluates model tumour malignancy

Molecular profiles of tissue plus circulating tumour DNA can better guide cancer care

Molecular profiles of tissue plus circulating tumour DNA can better guide cancer care

What factors affect patients’ decisions regarding active surveillance for low-risk prostate cancer?

What factors affect patients’ decisions regarding active surveillance for low-risk prostate cancer?

ASCO GI 2024: Adding immunotherapy-based combination to TACE improves progression-free survival in patients with most common liver cancer

ASCO GI 2024: Adding immunotherapy-based combination to TACE improves progression-free survival in patients with...

More from ecancer